Our platforms are catalyzing drug discoveryfor all major diseases
ELVIS™&ROSALYND™
We are therapeutic area agnostic, and are currently applying our platforms to novel hit discovery, hit-to-lead, and lead optimization campaigns in the following disease areas.
Neuroscience
Chronic pain ![]()
Infectious Disease
covid-19, non-tuberculosis mycobacterium (NTM) ![]()
Immunology
Psoriasis, Multiple Sclerosis ![]()
Oncology
Blood Cancers, Solid tumors ![]()
Aging
eye disorders, Osteoarthritis ![]()
Metabolism
Type I & Type II Diabetes, Hypercholesterolemia ![]()
